REG
Eevia has stopped the liquidity arrangement at Spotlight Stockmarket
Eevia Health Abp ("Eevia Health" or the "Company") has ended the arrangement with Mangold Fondkommission act as a liquidity provider for the company's shares at the Spotlight Sto...
Eevia Health secures an 868 KSEK sales order from a new customer for a new superior polyphenol extract
Eevia Health Plc ("Eevia" or "The Company") has won a 77 KEUR (868 KSEK) sales order from a new North American brand owner. The order is the first commercial customer for Feno-Ce...
REG
Communique from the Annual General Meeting in Eevia Health Plc 2024
The Annual General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on June 28, 2024, in Seinäjoki, Finland.
Eevia Health Plc receives a 578 KSEK (51 KEUR) sales order for a Bilberry extract product
Eevia Health Plc, ("Eevia" or "The Company"), has received a 51 KEUR sales order from a European nutraceutical brand owner.
REG
MAR
Eevia Health Plc enters a new stage in global sales project with an international market partner
Eevia Health Plc ("Eevia" or "The Company") has collaborated with a major international ingredient house over the last 12 months on possible commercial cooperation for the global...
REG
MAR
Eevia Health Plc partners up to enter 5-billion-euro eye-health market
Eevia Health Plc ("Eevia" or "The Company") received a letter of Intent with a global leader in eye health for a market launch in 2025 of Retinari™, a new game-changing eye-healt...
Eevia wins new customer with starting sales order for 2,1 MSEK (188 KEUR)
Eevia Health Plc ("Eevia" or "The Company") has received a first sales order for 188 KEUR (2,1 MSEK) from a large international ingredient company for Feno-Myrtillus® 25 organic...
New sales orders for 765 kSEK (68 kEUR) for Bilberry extracts
Eevia Health Plc ("Eevia" or "The Company") has received two sales orders for a total of 68 KEUR (765 KSEK) from two European customers for Feno-Myrtillus® organic extracts.
Eevia Health accepted as partner in the FOOD 2.0 - ECOSYSTEM
Eevia Health Plc ("Eevia" or "The Company") has been accepted by Valio as an ecosystem partner in the FOOD 2.0 program supported by Business Finland.
Valio, a leading food and d...
Eevia receives start order from a new Australian customer for 780 KSEK
Eevia Health Plc ("Eevia" or "The Company") has received a sales order for 69 kEUR (780 kSEK) from a new Australian customer for Feno-Sambucus 14, a standardized Elderberry extra...
REG
Eevia Health publishes information memorandum regarding the rights issue
Eevia Health Plc, ("Eevia" or "The Company") publishes an information memorandum regarding the invitation to subscribe for shares in Eevia today. The information memorandum, incl...
REG
NEW CORRECTION: Eevia Health publishes restated Interim Report Q1 2024
DUE TO TECHNICAL ERROR, THE SUMMARY OF FINANCIAL RESULTS WAS NOT UPDATED IN THE CORRECTION JUST RELEASED. THIS RELEASE HAS THE CORRECT SUMMARY OF UPDATED FINANCIAL FIGURES.Eevia...
REG
CORRECTION: Eevia Health publishes restated Interim Report Q1 2024
Eevia Health Plc, ("Eevia" or "The Company") publishes restated Q1 2024 Interim report due to differences between the statutory Financial Statements for 2023 that was published F...
REG
CORRECTION: Eevia Health Plc: Notice for Annual General Meeting for June 28, 2024
THE NOTICE FOR THE AGM WAS SENT OUT WITH THE MAR LABEL, WHICH IS INCORRECT. THEREFORE, WE RESEND THE NOTICE WITHOUT THE MAR LABEL.
Eevia Health Plc, ("Eevia" or "The Company"), h...
REG
MAR
Eevia Health Plc: Notice for Annual General Meeting for June 28, 2024
Eevia Health Plc, ("Eevia" or "The Company"), has today published the notice for the Annual General Meeting of Shareholders ("AGM") for June 28, 2024. The AGM will be held at the...
REG
MAR
Financial Statements and Annual report for fiscal year 2023
Eevia Health Plc ("Eevia" or "The Company") has today released its statutory financial statements and annual report for the year 2023 together with the Auditor's report for 2023....
REG
Communique from the EXTRAORDINARY General Meeting OF SHAREHOLDERS in Eevia Health Plc
The Extraordinary General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on June 5, 2024 in Seinäjoki, Finland, whereby the shareho...
REG
MAR
The board of directors of Eevia Health Plc has today decided on a rights issue
The board of directors of Eevia Health Plc ("Eevia" or the "Company") has today decided on a rights issue, for which the intention was communicated on May 17, with preferential r...
Om Eevia Health
Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.
Webbplats
eeviahealth.com/investors
Handelsinformation
Kurs ()
Förändring ()
